@article{7506ef456f3546fe9514d8b9d222b912,
title = "Use of BTK inhibitors with special focus on ibrutinib in Waldenstr{\"o}m macroglobulinemia: An expert panel opinion statement",
keywords = "BTK inhibitors, Waldenstr{\"o}m macroglobulinemia, ibrutinib, real-world, recommendations, BTK inhibitors, Waldenstr{\"o}m macroglobulinemia, ibrutinib, real-world, recommendations",
author = "S. Ferrero and Massimo Gentile and Luca Laurenti and Mauro, \{Francesca Romana\} and Maurizio Martelli and Paolo Sportoletti and Carlo Visco and Zinzani, \{Pier Luigi\} and Alessandra Tedeschi and M. Varettoni",
year = "2022",
doi = "10.1002/hon.2982",
language = "English",
volume = "40",
pages = "332--340",
journal = "Hematological Oncology",
issn = "1099-1069",
publisher = "John Wiley and Sons Ltd",
}